RecruitingNCT04707872

Trifecta-Heart cfDNA-MMDx Study

Trifecta-Heart cfDNA-MMDX Study: Comparing the DD-cfDNA Test to MMDx Microarray Test and Central HLA Antibody Test

Sponsor

University of Alberta

Enrollment

300 participants

Start Date

Jun 1, 2021

Study Type

OBSERVATIONAL

Conditions

heart transplant rejection

Summary

Demonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood transplant recipient and the Molecular Microscope® (MMDx) Diagnostic System results in indication and protocol biopsies from heart transplants.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying HLA antibody, MMDx diagnostic test, and others for people with heart transplant rejection. The study is currently recruiting participants at 12 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMMDx diagnostic test

Microarray test of gene expression in heart biopsies

DIAGNOSTIC_TESTProspera

Donor derived cell-free DNA in patient blood

DIAGNOSTIC_TESTHLA antibody

Centralized measurement of HLA antibodies in patient blood

Locations(12)

Baptist Health Institute for Research and Innovation

Little Rock, Arkansas, United States

Tampa General Hospital, 409 Bayshore Blvd.

Tampa, Florida, United States

Columbia University Medical Center, Columbia Interventional Cardiovascular Care

West New York, New Jersey, United States

Montefiore Medical Center, 3319 Rochambeau Avenue, 2nd FL

The Bronx, New York, United States

Annette C. and Harold C. Simmons Transplant Institute, BaylorScott&White Research Institute

Dallas, Texas, United States

Cardiovascular Medicine, University of Utah Health

Salt Lake City, Utah, United States

Cardiac Transplantation Laboratory, The Victor Chang Cardiac Research Institute

Darlinghurst, Australia

Division of Cardiology, University of Alberta

Edmonton, Alberta, Canada

Institute for Clinical and Experimental Medicine - IKEM Videnska 1958/9

Prague, Czechia

Heart Failure and Heart Transplant Unit, University of Bologna

Bologna, Italy

Silesian Center for Heart Diseases (Ś!ąskie Centrum Chorób Serca w Zabrzu

Zabrze, Poland

Advanced Heart Failure Transplant Unit

A Coruña, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04707872

Related Trials

Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients

NCT057327794 locations

A National Swedish Study Evaluating Dd-cfDNA for as a Diagnostic Biomarker for Rejection Surveillence in Heart Transplantation

NCT075317841 location

IMR-Heart Trasplant Study

NCT066560652 locations

Effect of the remote ischemic preconditioning on primary graft failure after heart transplantation: A Randomized Controlled Trial

ACTRN126150011965381 location